Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole in Obese Men with Hypogonadism
NCT00138710Phase 3Completed
- Sponsor
- Rijnstate
- Start
- Aug 2005
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypogonadotropic hypogonadism (HH) comparing Letrozole with Placebo (2 arms). Primary endpoints: Body weight at 26 weeks, Body Mass Index at 26 weeks and 7 more. Started Aug 2005; status: completed.
02
Drugs
letrozole
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT00138710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138710.